Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Cardiovascular
Boston Scientific gets FDA approval for drug-coated balloon catheter
By
LabPulse.com staff writers
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Agent drug-coated balloon, a paclitaxel-coated balloon catheter sized to fit within blocked or constricted coronary arteries to treat coronary in-stent restenosis.
March 4, 2024
International consortium aims to develop precision approach for CVD
By
Matt Limb
An international collaboration has begun to develop personalized treatments for patients with cardiovascular disease, combining genetic analysis and better integration of health data.
February 21, 2024
Abbott begins clinical development of a pulsed field ablation device
By
Nick Paul Taylor
Abbott has begun clinical development of a pulsed field ablation (PFA) device that could rival Boston Scientific, Johnson & Johnson, and Medtronic for an emerging atrial fibrillation (AFib) market.
January 24, 2024
High-sensitivity assay improves diagnosis for patients with heart muscle injury in U.K. study
By
Matt Limb
A high-sensitivity blood test can improve diagnosis for 1 in 5 patients who have a heart muscle injury, according to a U.K. hospital study.
December 6, 2023
Potential drug target to prevent small vessel disease identified in study
By
Matt Limb
Scientists say lab-grown small blood vessels used in new disease models point to a theoretical potential treatment for a major cause of stroke and vascular dementia.
November 29, 2023
AI-powered blood test supports risk stratification of heart disease patients
By
Nick Paul Taylor
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
November 27, 2023
AI concurs with humans in heart failure test, suggesting scalable approach to clinical trials
By
Nick Paul Taylor
Artificial intelligence (AI) may make clinical trials more efficient by accurately identifying events at scale, a retrospective analysis has found.
November 21, 2023
PLK1 inhibitors show promise for inflammatory disease treatment, study shows
By
Matt Limb
A cancer drug in late-stage clinical trials could offer hope for treating a wide range of inflammatory diseases, including gout and heart disease, say researchers.
November 14, 2023
CRISPR Therapeutics to present data from gene therapy programs at AHA Scientific Sessions
By
LabPulse.com staff writers
Biopharmaceutical company CRISPR Therapeutics will present preclinical data from its investigational gene therapy treatment programs for cardiovascular disease at the AHA Scientific Sessions 2023 in Philadelphia on November 11.
November 6, 2023
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
By
Nick Paul Taylor
Genetic factors are unlikely to directly drive the increased rate of cardiovascular disease in schizophrenia patients but may influence lifestyle, according to a paper in the American Journal of Psychiatry.
September 29, 2023
High troponin linked with heightened mortality risk from any cause
By
Matt Limb
A high level of troponin may signal a heightened risk of death from any cause within the next few years, even in the absence of known or suspected cardiovascular disease (CVD), according to recently published research.
August 24, 2023
Can a simple saliva test ID CVD risk?
By
Melissa Busch
Researchers in Canada say that the early warning signs of cardiovascular disease may be gleaned from a simple saliva sample.
August 24, 2023
Page 1 of 8
Next Page